DSIB // DIRECTORY // BIO // REV 2026.10
CATEGORY 27
BIOTECHNOLOGY, RESEARCH SECURITY & LIFE SCIENCES INTELLIGENCE
Defensive research-security, partner and technology intelligence for biotechnology and advanced life-sciences organisations.
PROTECTING RESEARCH THROUGH EVIDENCE AND CONTEXT.
Independent, analytical and advisory. Services are delivered under defined mandates and are subject to applicable law, jurisdiction, client authorisation and professional obligations. DSIB does not act as a public authority or exercise statutory powers.
01
MANDATE
Support institutional integrity and research continuity through documented analysis of partners, funding, technology relationships and external dependencies.
Protecting research through evidence and context.
02
SCOPE
Biotechnology ecosystems; research-security context; proportionate partner and institution due diligence; intellectual property and technology-transfer relationships; supply chains; biosecurity governance; defensive cyber and information risk; recurring intelligence.
03
CLIENTS
PRIMARY CLIENTS: BIOTECHNOLOGY COMPANIES, RESEARCH INSTITUTES, UNIVERSITIES, LABORATORIES, INVESTORS AND LIFE-SCIENCES PARTNERSHIPS.
ECOSYSTEMS · FUNDING · INSTITUTIONAL RELATIONSHIPS
Maps biotechnology ecosystems and the commercial, institutional and funding relationships shaping strategic decisions. Research supports assessment of collaboration and market context while distinguishing verified evidence from scientific or commercial uncertainty.
Work is defensive and non-experimental. It excludes pathogen enhancement, weaponisation and hazardous experimental protocols, and does not validate scientific efficacy or direct clinical decisions.
INTELLIGENCE CAPABILITIES
01.01 BIOTECHNOLOGY ECOSYSTEM RELATIONSHIP MAPPING
01.02 LIFE-SCIENCES INSTITUTIONAL LANDSCAPE RESEARCH
01.03 PUBLIC RESEARCH FUNDING PROGRAMME ANALYSIS
01.04 BIOTECHNOLOGY COMMERCIAL PARTNERSHIP CONTEXT REVIEW
01.05 RESEARCH COMMERCIALISATION MARKET ASSESSMENT
01.06 ADVANCED LIFE-SCIENCES POLICY HORIZON SCANNING
01.07 BIOTECHNOLOGY INCUBATOR OWNERSHIP RESEARCH
01.08 PUBLIC SCIENTIFIC COLLABORATION TREND ANALYSIS
01.09 LIFE-SCIENCES INVESTMENT RELATIONSHIP MAPPING
01.10 RESEARCH PLATFORM COMMERCIAL CLAIM CORROBORATION
01.11 BIOTECHNOLOGY CONSORTIUM GOVERNANCE CONTEXT REVIEW
01.12 PUBLIC INNOVATION STRATEGY COMPARISON
01.13 LIFE-SCIENCES MARKET DEPENDENCY ASSESSMENT
01.14 BIOTECHNOLOGY STRATEGIC SCENARIO DEVELOPMENT
01.15 EXECUTIVE RESEARCH ECOSYSTEM BRIEFINGS
01.16 MATERIAL LIFE-SCIENCES PARTNERSHIP ALERTS
DSIB-BIO-01
BIOTECHNOLOGY AND LIFE-SCIENCES INTELLIGENCE
PROTECTIVE CONTEXT · DEPENDENCIES · PROPORTIONATE RESPONSE
Examines documented external risks and institutional dependencies relevant to research protection. Intelligence helps authorised teams prioritise questions about access, collaboration and continuity without treating nationality, affiliation or allegation alone as evidence of misconduct.
The scope excludes covert intrusion, discriminatory profiling and operational targeting. Protective measures and access decisions remain with accountable institutions under applicable law and proportionate procedures.
INTELLIGENCE CAPABILITIES
02.01 RESEARCH SECURITY REQUIREMENT ASSESSMENT
02.02 PUBLIC RESEARCH ESPIONAGE CASE CONTEXT REVIEW
02.03 INSTITUTIONAL RESEARCH DEPENDENCY MAPPING
02.04 COLLABORATION SECURITY POLICY COMPARISON
02.05 SENSITIVE RESEARCH PARTNERSHIP EXPOSURE REVIEW
02.06 RESEARCH EVENT PROTECTIVE CONTEXT ASSESSMENT
02.07 ACADEMIC IMPERSONATION INDICATOR RESEARCH
02.08 PUBLIC RESEARCH INTERFERENCE CLAIM CORROBORATION
02.09 RESEARCH TRAVEL EXTERNAL RISK BRIEFINGS
02.10 INSTITUTIONAL INFORMATION EXPOSURE CONTEXT REVIEW
02.11 RESEARCH SECURITY STAKEHOLDER RESPONSIBILITY MAPPING
02.12 PROTECTIVE INTELLIGENCE EVIDENCE GAP ANALYSIS
02.13 RESEARCH CONTINUITY THREAT SCENARIO ASSESSMENT
02.14 PROPORTIONATE SECURITY ESCALATION CRITERIA REVIEW
02.15 EXECUTIVE RESEARCH PROTECTION SITUATION REPORTS
02.16 RESEARCH SECURITY INTELLIGENCE COVERAGE EVALUATION
DSIB-BIO-02
RESEARCH-SECURITY INTELLIGENCE
PROFESSIONAL RECORDS · PARTNERS · INSTITUTIONAL INTEGRITY
Provides proportionate, mandate-specific research on institutions, commercial partners and relevant professional representations. Corroborated public or authorised records support accountable assessment of credentials, affiliations and disclosed relationships.
Personal research is limited to relevant professional matters with lawful authority and safeguards. Findings do not infer sensitive traits, establish guilt or determine employment eligibility; institutions retain responsibility for fair decisions.
INTELLIGENCE CAPABILITIES
03.01 RESEARCH INSTITUTION GOVERNANCE BACKGROUND REVIEW
03.02 COLLABORATION PARTNER OWNERSHIP ASSESSMENT
03.03 AUTHORISED PROFESSIONAL CREDENTIAL CORROBORATION
03.04 RELEVANT RESEARCH AFFILIATION VERIFICATION
03.05 PUBLIC PUBLICATION RECORD CONSISTENCY REVIEW
03.06 RESEARCH PARTNER FUNDING RELATIONSHIP MAPPING
03.07 INSTITUTIONAL LITIGATION AND ENFORCEMENT RESEARCH
03.08 PUBLIC RESEARCH INTEGRITY FINDING REVIEW
03.09 PROFESSIONAL REPRESENTATION EVIDENCE GAP ANALYSIS
03.10 COLLABORATION REFERENCE CORROBORATION
03.11 RESEARCH PARTNER CONFLICT-OF-INTEREST ASSESSMENT
03.12 INSTITUTIONAL ACCREDITATION CLAIM RESEARCH
03.13 LIFE-SCIENCES CONSORTIUM PARTICIPANT DUE DILIGENCE
03.14 RESEARCH PARTNER ADVERSE INFORMATION EVALUATION
03.15 DOCUMENTED PARTNER INTEGRITY BRIEFINGS
03.16 MATERIAL INSTITUTIONAL BACKGROUND CHANGE ALERTS
DSIB-BIO-03
PARTNER, RESEARCHER AND INSTITUTION DUE DILIGENCE
INTELLECTUAL PROPERTY · TRANSFERS · COMMERCIAL INTEGRITY
Researches the parties and public records surrounding research commercialisation and technology-transfer relationships. Intelligence helps responsible teams identify conflicts, opaque interests and unresolved integrity questions requiring specialist review.
The service does not obtain trade secrets unlawfully, assess freedom to operate, provide patent opinions or decide export permissions. Legal and technical conclusions remain with qualified advisers.
INTELLIGENCE CAPABILITIES
04.01 RESEARCH SPIN-OUT OWNERSHIP RECONSTRUCTION
04.02 TECHNOLOGY LICENSEE BACKGROUND DUE DILIGENCE
04.03 PUBLIC RESEARCH IP DISPUTE ANALYSIS
04.04 TECHNOLOGY-TRANSFER INTERMEDIARY INTEGRITY RESEARCH
04.05 RESEARCH COMMERCIALISATION RELATED-PARTY MAPPING
04.06 PUBLIC PATENT ASSIGNMENT RELATIONSHIP REVIEW
04.07 LICENSING PARTNER ENFORCEMENT RECORD RESEARCH
04.08 RESEARCH REVENUE REPRESENTATION CORROBORATION
04.09 TECHNOLOGY TRANSFER FUNDING NEXUS ASSESSMENT
04.10 UNDISCLOSED COMMERCIAL INTEREST CONTEXT RESEARCH
04.11 PUBLIC RESEARCH MISAPPROPRIATION CASE REVIEW
04.12 INNOVATION CONTRACT COUNTERPARTY BACKGROUND ANALYSIS
04.13 RESEARCH SPONSORSHIP CONFLICT MAPPING
04.14 COMMERCIALISATION EVIDENCE PRESERVATION PLANNING
04.15 TECHNOLOGY-TRANSFER INTEGRITY DECISION BRIEFINGS
04.16 MATERIAL RESEARCH IP RELATIONSHIP MONITORING
DSIB-BIO-04
IP, TECHNOLOGY-TRANSFER AND INTEGRITY INTELLIGENCE
SUPPLIERS · SERVICE DEPENDENCIES · CONTINUITY
Connects life-sciences supplier ownership, commercial relationships and external disruption indicators. Research supports accountable procurement and continuity teams in assessing integrity, concentration and the reliability of commercial representations.
Research does not source controlled biological materials or provide hazardous procurement pathways. Scientific suitability, biosafety, product quality and regulated transfers remain with authorised specialists.
INTELLIGENCE CAPABILITIES
05.01 RESEARCH SUPPLIER CORPORATE DUE DILIGENCE
05.02 LABORATORY SERVICE PROVIDER BACKGROUND REVIEW
05.03 LIFE-SCIENCES EQUIPMENT VENDOR OWNERSHIP MAPPING
05.04 RESEARCH CONSUMABLES MARKET CONCENTRATION ANALYSIS
05.05 SCIENTIFIC DATA SERVICE DEPENDENCY ASSESSMENT
05.06 LIFE-SCIENCES LOGISTICS PARTNER INTEGRITY RESEARCH
05.07 RESEARCH SUPPLIER FINANCIAL DISTRESS MONITORING
05.08 PUBLIC LABORATORY EQUIPMENT RECALL RESEARCH
05.09 SUPPLIER COMMERCIAL REPRESENTATION CORROBORATION
05.10 RESEARCH OUTSOURCING RELATIONSHIP MAPPING
05.11 LIFE-SCIENCES SUPPLY GEOGRAPHIC EXPOSURE REVIEW
05.12 PUBLIC SCIENTIFIC SUPPLY RESTRICTION POLICY RESEARCH
05.13 RESEARCH PROCUREMENT INTERMEDIARY BACKGROUND ANALYSIS
05.14 SUPPLY CONTINUITY SCENARIO BRIEFINGS
05.15 CRITICAL RESEARCH VENDOR CHANGE ALERTS
05.16 LIFE-SCIENCES PROCUREMENT INTELLIGENCE REGISTERS
DSIB-BIO-05
LIFE-SCIENCES SUPPLY-CHAIN INTELLIGENCE
GOVERNANCE · OVERSIGHT · DEFENSIVE CONTEXT
Synthesises published governance developments and institutional relationships relevant to responsible life-sciences research. Intelligence helps leadership identify oversight questions and maintain awareness of public policy and documented integrity concerns.
This is governance research, not laboratory safety certification or biological experimentation. It excludes hazardous protocols, pathogen optimisation, weaponisation and information intended to enable biological misuse.
INTELLIGENCE CAPABILITIES
06.01 PUBLIC BIOSECURITY GOVERNANCE POLICY MONITORING
06.02 INSTITUTIONAL BIOSAFETY OVERSIGHT CONTEXT RESEARCH
06.03 RESPONSIBLE RESEARCH FRAMEWORK COMPARISON
06.04 PUBLIC DUAL-USE GOVERNANCE DEVELOPMENT TRACKING
06.05 BIOSECURITY OVERSIGHT STAKEHOLDER MAPPING
06.06 RESEARCH FUNDING SAFEGUARD CONTEXT REVIEW
06.07 PUBLISHED BIOSECURITY INCIDENT GOVERNANCE ANALYSIS
06.08 LIFE-SCIENCES REPORTING OBLIGATION HORIZON SCANNING
06.09 INSTITUTIONAL ASSURANCE REPRESENTATION CORROBORATION
06.10 BIOSECURITY TRAINING PROVIDER BACKGROUND RESEARCH
06.11 RESEARCH GOVERNANCE ACCOUNTABILITY MAPPING
06.12 PUBLIC SCIENTIFIC ETHICS GUIDANCE SYNTHESIS
06.13 BIOSECURITY GOVERNANCE EVIDENCE GAP ASSESSMENT
06.14 INSTITUTIONAL OVERSIGHT SCENARIO BRIEFINGS
06.15 BOARD-LEVEL BIOSECURITY GOVERNANCE SUMMARIES
06.16 MATERIAL RESEARCH SAFEGUARD POLICY ALERTS
DSIB-BIO-06
BIOSECURITY GOVERNANCE INTELLIGENCE
DEFENSIVE CYBER · DATA RELATIONSHIPS · INFORMATION INTEGRITY
Examines documented cyber events and authorised information-risk indicators affecting research organisations. Intelligence supports proportionate review of digital dependencies, data-service relationships and concerns requiring formal security or integrity procedures.
No unauthorised access, interception or covert employee surveillance is included. Personal information is minimised; indicators are not proof of intent, and employment or disciplinary decisions remain with accountable institutions.
INTELLIGENCE CAPABILITIES
07.01 RESEARCH SECTOR CYBER THREAT CONTEXT ASSESSMENT
07.02 PUBLIC LABORATORY CYBER INCIDENT RESEARCH
07.03 RESEARCH INSTITUTION DOMAIN IMPERSONATION MONITORING
07.04 SCIENTIFIC CLOUD PROVIDER BACKGROUND DUE DILIGENCE
07.05 RESEARCH DATA PROCESSOR OWNERSHIP ASSESSMENT
07.06 PUBLIC RESEARCH CREDENTIAL EXPOSURE CONTEXT REVIEW
07.07 CLIENT-AUTHORISED RESEARCH INCIDENT CHRONOLOGY
07.08 SCIENTIFIC SOFTWARE VENDOR INCIDENT ANALYSIS
07.09 RESEARCH COLLABORATION DATA DEPENDENCY MAPPING
07.10 PUBLIC RESEARCH DATA MISUSE CASE REVIEW
07.11 AUTHORISED ACCESS-GOVERNANCE EVIDENCE GAP ASSESSMENT
07.12 RESEARCH DATA TRANSFER POLICY CONTEXT ANALYSIS
07.13 DOCUMENTED INSIDER-RISK ALLEGATION CORROBORATION
07.14 PROPORTIONATE INFORMATION-RISK ESCALATION DESIGN
07.15 EXECUTIVE RESEARCH CYBER SITUATION BRIEFINGS
07.16 DEFENSIVE RESEARCH INTELLIGENCE COVERAGE REVIEW
DSIB-BIO-07
CYBER, DATA AND INSIDER-THREAT INTELLIGENCE
AGREED COVERAGE · CONTINUOUS CONTEXT · DECISION SUPPORT
Provides recurring research-security intelligence across agreed institutions, counterparties and external developments. Scheduled reporting and defined alerts help authorised leaders maintain a documented view of changing relationships and protective priorities.
Mandates define sources, lawful access, review intervals and escalation responsibilities. Monitoring does not guarantee complete threat detection or replace institutional biosafety, data-protection and research-governance obligations.
INTELLIGENCE CAPABILITIES
08.01 RESEARCH INTELLIGENCE REQUIREMENT DEFINITION
08.02 INSTITUTIONAL MONITORING PLAN DEVELOPMENT
08.03 RESEARCH PARTNER WATCHLIST DESIGN
08.04 BIOTECHNOLOGY FUNDING CHANGE TRACKING
08.05 RESEARCH GOVERNANCE HORIZON-SCANNING REPORTS
08.06 LIFE-SCIENCES INTEGRITY EVENT TRIAGE
08.07 RESEARCH SUPPLIER DEPENDENCY ALERTING
08.08 SCHEDULED RESEARCH SECURITY ASSESSMENTS
08.09 EXECUTIVE COLLABORATION RISK DASHBOARDS
08.10 BOARD-LEVEL RESEARCH PROTECTION BRIEFINGS
08.11 RESEARCH CRISIS INTELLIGENCE COORDINATION
08.12 PARTNER REVIEW EVIDENCE REFRESH PROGRAMMES
08.13 RESEARCH SOURCE COVERAGE EVALUATION
08.14 ANALYTICAL CONFIDENCE AND LIMITATION REGISTERS
08.15 RESEARCH INTELLIGENCE ESCALATION WORKFLOW REVIEW
08.16 INSTITUTIONAL INTELLIGENCE PROGRAMME EVALUATION
DSIB-BIO-08